Vaccine Vaccine, 38, 9, pp. 2229-2240 Angelidou, A, Conti, M G, Diray-Arce, J, Benn, C S, Shann, F, Netea, M G, Liu, M, Potluri, L P, Sanchez-Schmitz, G, Husson, R, Ozonoff, A, Kampmann, B, van Haren, S D & Levy, O 2020, ' Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation ', Vaccine, vol. 38, no. 9, pp. 2229-2240 . https://doi.org/10.1016/j.vaccine.2019.11.060 Vaccine, 38, 2229-2240